The possibility of our patient having de novo AML with JAK2-V617F mutation was considered, but the multiple bone marrow examinations suggesting MPN, a subsequent examination consistent with AML, and the presence of the mutation made the diagnosis of MPN with rapid evolution into sAML more likely. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.